Thermo Fisher Is Embedding AI Across Its Clinical Trials Business — Here’s Why It Matters
The contract research organization (CRO) landscape is shifting. Thermo Fisher Scientific, one of the largest players in clinical research with over $40 billion in annual revenue, is integrating AI directly into its drug development operations through a collaboration with OpenAI. This isn’t a pilot program or a proof of concept. Thermo Fisher is embedding AI…
